2,3-Dihydro-1-H-pyrido[3,4-B][1,4]oxazine | CAS 194022-45-2

Element: dihydro oxazine pyrido

Page Content Identification Properties Suppliers Prices & Availability Get Quick Quote ☰

Identification Properties Suppliers Prices & Availability Get Quick Quote

C-S » Chemicals » dihydro-pyrido-oxazine-PX2568567

Identification

2,3-Dihydro-1-H-pyrido[3,4-B][1,4]oxazine

CAS:

194022-45-2

EINECS:

Molecular Formula:

C₇H₈ N₂ O

MDL:

MFCD13176662

Synonym:

2,3-dihydro-1h-pyrido[3,4-b][1,4]oxazine aldrichcpr ; 1h-pyrido[3,4-b][1,4]oxazine,2,3-dihydro-(9ci) ; 2,3-dihydro-1h-pyrido[3,4-b][1,4]oxazine dihydrochloride ; 2,3-dihydro-1h-4-oxa-1,6-diaza-naphthalene ; 1h-pyrido[3,4-b][1,4]oxazine,2,3-dihydro- ; 1h-pyrido[3,4-b][1,4]oxazine, 2,3-dihydro-

Suppliers

Get Quick Quote

CAS equal suppliers

2,3-Dihydro-1H-pyrido[3,4-b][1,4]oxazine

Hangzhou J&H Chemical Co., Ltd.

HJC496019840

2,3-Dihydro-1h-pyrido[3,4-b][1,4]oxazine

Key Organics Limited

GS-6008

2,3-Dihydro-1h-pyrido[3,4-b][1,4]oxazine

Huateng Pharmaceutical Co.,Ltd

90368

2,3-Dihydro-1H-pyrido[3,4-b][1,4]oxazine

Chemlyte Solutions

CS28808640

Prices & Availability

Data is processed

Properties for 2,3-Dihydro-1-H-pyrido[3,4-B][1,4]oxazine

Molecular Weight:

136.15122 g·mol−1

Hazard Statements

GHS03
Harmful

Acute toxicity (oral, dermal, inhalation), category 4
Skin irritation, categories 2, 3
Eye irritation, category 2A
Skin sensitization, category 1
Specific target organ toxicity following single exposure, category 3
- Respiratory tract irritation
- Narcotic effects

Not used

with the "skull and crossbones" pictogram
for skin or eye irritation if:
the "corrosion" pictogram also appears
the "health hazard" pictogram is used to indicate respiratory sensitization

Safety & Transport Information

Alternative Distributors of [2,3-Dihydro-1-H-pyrido[3,4-B][1,4]oxazine]

Producers or manufacturers change the product range from time to time. The following companies
have appeared as suppliers in the past / currently not verified

Matrix Scientific | Adesis, Inc.